Goran Ando is of EyePoint Pharmaceuticals, Inc.. Currently has a direct ownership of 13,150 shares of EYPT, which is worth approximately $94,680. The most recent transaction as insider was on Aug 21, 2024, when has been sold 5,000 shares (Common Stock) at a price of $7.95 per share, resulting in proceeds of $39,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.2K
0% 3M change
61.35% 12M change
Total Value Held $94,680

GORAN ANDO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 21 2024
BUY
Open market or private purchase
$39,750 $7.95 p/Share
5,000 Added 27.55%
13,150 Common Stock
Feb 09 2023
BUY
Exercise of conversion of derivative security
-
3,250 Added 28.51%
8,150 Common Stock
Feb 09 2022
BUY
Exercise of conversion of derivative security
-
2,750 Added 35.95%
4,900 Common Stock
Feb 28 2021
BUY
Exercise of conversion of derivative security
-
2,150 Added 50.0%
2,150 Common Stock

Also insider at

SELB
SELECTA BIOSCIENCES INC Healthcare
GA

Goran Ando

Watertown, MA

Track Institutional and Insider Activities on EYPT

Follow EyePoint Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EYPT shares.

Notify only if

Insider Trading

Get notified when an Eye Point Pharmaceuticals, Inc. insider buys or sells EYPT shares.

Notify only if

News

Receive news related to EyePoint Pharmaceuticals, Inc.

Track Activities on EYPT